Market Pathways Top Five: September 2021

article image
ARTICLE SUMMARY:

The top five Market Pathways articles posted in September to MyStrategist.com, chosen by readers and editors, include CMS’ proposed repeal of the MCIT rule, getting reimbursement for AI tech, Doc Depot, our Q&A with MDIC’s new VP of Health Economics & Patient Value, and robust regulatory activity in Asia.

The top five Market Pathways September articles.

Subscribers, click through to read the full articles. Non-subscribers, take advantage of our free trial offer.

#1: MCIT Rule May Be Toast, But There’s More on the Medicare Menu

CMS’ proposed repeal of its planned automatic temporary coverage pathway for FDA Breakthrough Devices sends a bad signal to medtech investors and innovators. But it’s worth taking time to see what the agency does next on this issue, and other policy matters with an even more expansive impact on the device industry, before coming to any final conclusions about CMS’ plans for the sector, opines Executive Editor David Filmore.

 

#2: Seeking Reimbursement for AI Tech? Five Things to Remember

Devices driven by artificial intelligence algorithms are becoming more prevalent in healthcare, but reimbursement remains a challenge. Deborah Godes from McDermott+Consulting spoke to Market Pathways on the topic, offering insights for companies entering the coverage, coding, and payment trenches for AI tech in the latest "From the Experts" column.

 

#3: Pathways Document Depot: Cataloging Medtech Policy

A sortable and searchable running inventory of global medtech regulatory and policy official documents, including rules, guidance documents, memos, white papers, and more from national authorities, non-governmental groups, and global organizations.

 

#4: Value-Based Tech Assessment: Finding Common Ground. An Interview with MDIC’s Jo Carol Hiatt

In its unique position as a public/private partnership, the Medical Device Innovation Consortium is looking to correlate the diverse views of key constituencies in assessing the value of innovative technologies. To spearhead this effort, the organization tapped Jo Carol Hiatt, MD, a surgeon who directed Kaiser Permanente’s tech assessment team. Here, Hiatt explains how her initial focus is on real-world evidence and patients’ perspectives as ways to reach common ground.

 

#5: Docs of the Month: Asia Leads the Pack

China, India, and Singapore came out with the most medtech policy documents last month, as tracked by Pathways’ Document Depot, reflecting the robust efforts across Asia to forge new regulatory frameworks.

 

  Trial MyStrategist.com  and unlock 7-days of exclusive  subscriber-only access  to the medical device industry's most trusted strategic publications:  MedTech Strategist  &  Market Pathways . For more information on our demographics and current readership  click here .

×



Articles from Nancy Dvorin:

Perspective & Commentary

Digital Edition: MedTech Strategist February 2024

We examine the opportunity for intravascular ultrasound in peripheral vascular disease, one of the largest endovascular markets; FIRE1 moves closer to proving the success of its novel approach to heart failure and perhaps the build-to-buy model. Northwell Health's VP of data strategy discusses leveraging the "data lake" to meet clinical and operational needs, both internally and with external partners. Plus profiles of ViCentra, Insight Medbotics, and VUZE Medical.

Read Article